Timothy Triche

WaferGen Bio-systems, Inc. used to provide genomic technology solutions for single-cell analysis and clinical research. The firm offered SmartChip Real-Time polymerase chain reaction (PCR) system, which provided a suite of gene expression and genome analysis technologies enabling biomarker discovery and validation on a single platform with the sensitivity and accuracy of PCR. The company was founded by Alnoor Shivji, Victor Joseph and Amjad Huda on October 22, 2002 and was headquartered in Fremont, CA.

Decipher Biosciences, Inc. is a commercial-stage precision oncology company which engages in patient care improvement. The Company?s differentiated approach measures the biological activity of a patient?s entire tumor genome, known as whole transcriptome analysis, and applies proprietary machine learning algorithms to improve therapy selection and accelerate adoption of new therapies into the standard of care. Its novel prostate cancer genomic testing products examine the underlying biology of a patient?s tumor, enabling physicians to select an optimal therapy. The firm?s whole transcriptome analysis of clinical patient samples from its commercial channel and its participation in practice-changing clinical trials has allowed it to build and expand its Decipher GRID database GRID. The company was founded by Elai Davicioni, Timothy J. Triche, Bruce A. Schmidt, and Jonathan D. Buckley and is headquartered in San Diego, CA.

The Association for Molecular Pathology develops molecular diagnostics. The American company was founded by Jeffrey Cossman.

Lifecode, Inc. provides clinical laboratory and diagnostic services for the human genome. It offers sequencing technology and bioinformatics which provides clinical information designed to help physicians make the treatment decisions for their patients. The company was founded by Dietrich A. Stephan, Sivan Bercovici, Eugene Fratkin and Helen Wang in 2011 and is headquartered in Foster City, CA.

Sanguine BioSciences, Inc. provides biomedical research services and develops drugs. The firm maintains a bio repository of frozen samples from donors in various disease indications such as PBMC, PBMC subtypes, plasma, serum, cerebral spinal fluid, blood units and DNA/RNA. The company was founded by Brian Neman and Gerald H. Lee in 2010 and is headquartered in Sherman Oaks, CA.

Part of MedGenome Labs Pvt Ltd., MedGenome, Inc. engages in research and development of genomics. The company is located in the US.